What’s new in fibroblastic tumors?

go back to reference Kao YC, Flucke U, Eijkelenboom A, Zhang L, Sung YS, Suurmeijer AJH, Antonescu CR (2018) Novel EWSR1-SMAD3 gene fusions in a group of acral fibroblastic spindle cell neoplasms. Am J Surg Pathol 42:522–528. https://doi.org/10.1097/PAS.0000000000001002CrossRefPubMedPubMedCentral Kao YC, Flucke U, Eijkelenboom A, Zhang L, Sung YS, Suurmeijer AJH, Antonescu CR (2018) Novel EWSR1-SMAD3 gene fusions in a group of acral fibroblastic spindle cell neoplasms. Am J Surg Pathol 42:522–528. https://​doi.​org/​10.​1097/​PAS.​0000000000001002​CrossRefPubMedPubMedCentral

go back to reference Michal M, Berry RS, Rubin BP, Kilpatrick SE, Agaimy A, Kazakov DV, Steiner P, Ptakova N, Martinek P, Hadravsky L, Michalova K, Szep Z, Michal M (2018) EWSR1-SMAD3-rearranged fibroblastic tumor: an emerging entity in an increasingly more complex group of fibroblastic/myofibroblastic neoplasms. Am J Surg Pathol 42:1325–1333. https://doi.org/10.1097/PAS.0000000000001109CrossRefPubMed Michal M, Berry RS, Rubin BP, Kilpatrick SE, Agaimy A, Kazakov DV, Steiner P, Ptakova N, Martinek P, Hadravsky L, Michalova K, Szep Z, Michal M (2018) EWSR1-SMAD3-rearranged fibroblastic tumor: an emerging entity in an increasingly more complex group of fibroblastic/myofibroblastic neoplasms. Am J Surg Pathol 42:1325–1333. https://​doi.​org/​10.​1097/​PAS.​0000000000001109​CrossRefPubMed

go back to reference Carter JM, Weiss SW, Linos K, DiCaudo DJ, Folpe AL (2014) Superficial CD34-positive fibroblastic tumor: report of 18 cases of a distinctive low-grade mesenchymal neoplasm of intermediate (borderline) malignancy. Mod Pathol 27:294–302. https://doi.org/10.1038/modpathol.2013.139CrossRefPubMed Carter JM, Weiss SW, Linos K, DiCaudo DJ, Folpe AL (2014) Superficial CD34-positive fibroblastic tumor: report of 18 cases of a distinctive low-grade mesenchymal neoplasm of intermediate (borderline) malignancy. Mod Pathol 27:294–302. https://​doi.​org/​10.​1038/​modpathol.​2013.​139CrossRefPubMed

go back to reference Lao IW, Yu L, Wang J (2017) Superficial CD34-positive fibroblastic tumour: a clinicopathological and immunohistochemical study of an additional series. Histopathology 70:394–401. https://doi.org/10.1111/his.13088CrossRefPubMed Lao IW, Yu L, Wang J (2017) Superficial CD34-positive fibroblastic tumour: a clinicopathological and immunohistochemical study of an additional series. Histopathology 70:394–401. https://​doi.​org/​10.​1111/​his.​13088CrossRefPubMed

go back to reference Puls F, Pillay N, Fagman H, Palin-Masreliez A, Amary F, Hansson M, Kindblom LG, McCulloch TA, Meligonis G, Muc R, Rissler P, Sumathi VP, Tirabosco R, Hofvander J, Magnusson L, Nilsson J, Flanagan AM, Mertens F (2019) PRDM10-rearranged soft tissue tumor: a clinicopathologic study of 9 cases. Am J Surg Pathol 43:504–513. https://doi.org/10.1097/PAS.0000000000001207CrossRefPubMed Puls F, Pillay N, Fagman H, Palin-Masreliez A, Amary F, Hansson M, Kindblom LG, McCulloch TA, Meligonis G, Muc R, Rissler P, Sumathi VP, Tirabosco R, Hofvander J, Magnusson L, Nilsson J, Flanagan AM, Mertens F (2019) PRDM10-rearranged soft tissue tumor: a clinicopathologic study of 9 cases. Am J Surg Pathol 43:504–513. https://​doi.​org/​10.​1097/​PAS.​0000000000001207​CrossRefPubMed

go back to reference Michal M, Kazakov DV, Hadravsky L, Kinkor Z, Kuroda N, Michal M (2015) High-grade myxoinflammatory fibroblastic sarcoma: a report of 23 cases. Ann Diagn Pathol 19:157–163. https://doi.org/10.1016/j.anndiagpath.2015.03.012CrossRefPubMed Michal M, Kazakov DV, Hadravsky L, Kinkor Z, Kuroda N, Michal M (2015) High-grade myxoinflammatory fibroblastic sarcoma: a report of 23 cases. Ann Diagn Pathol 19:157–163. https://​doi.​org/​10.​1016/​j.​anndiagpath.​2015.​03.​012CrossRefPubMed

go back to reference Marino-Enriquez A, Fletcher CD (2012) Angiofibroma of soft tissue: clinicopathologic characterization of a distinctive benign fibrovascular neoplasm in a series of 37 cases. Am J Surg Pathol 36:500–508. https://doi.org/10.1097/PAS.0b013e31823defbeCrossRefPubMed Marino-Enriquez A, Fletcher CD (2012) Angiofibroma of soft tissue: clinicopathologic characterization of a distinctive benign fibrovascular neoplasm in a series of 37 cases. Am J Surg Pathol 36:500–508. https://​doi.​org/​10.​1097/​PAS.​0b013e31823defbe​CrossRefPubMed

go back to reference Bekers EM, Groenen P, Verdijk MAJ, Raaijmakers-van Geloof WL, Roepman P, Vink R, Gilhuijs NDB, van Gorp JM, Bovee J, Creytens DH, Flanagan AM, Suurmeijer AJH, Mentzel T, Arbajian E, Flucke U (2017) Soft tissue angiofibroma: clinicopathologic, immunohistochemical and molecular analysis of 14 cases. Genes Chromosomes Cancer 56:750–757. https://doi.org/10.1002/gcc.22478CrossRefPubMed Bekers EM, Groenen P, Verdijk MAJ, Raaijmakers-van Geloof WL, Roepman P, Vink R, Gilhuijs NDB, van Gorp JM, Bovee J, Creytens DH, Flanagan AM, Suurmeijer AJH, Mentzel T, Arbajian E, Flucke U (2017) Soft tissue angiofibroma: clinicopathologic, immunohistochemical and molecular analysis of 14 cases. Genes Chromosomes Cancer 56:750–757. https://​doi.​org/​10.​1002/​gcc.​22478CrossRefPubMed

go back to reference Yamada Y, Yamamoto H, Kohashi K, Ishii T, Iura K, Maekawa A, Bekki H, Otsuka H, Yamashita K, Tanaka H, Hiraki T, Mukai M, Shirakawa A, Shinnou Y, Jinno M, Yanai H, Taguchi K, Maehara Y, Iwamoto Y, Oda Y (2016) Histological spectrum of angiofibroma of soft tissue: histological and genetic analysis of 13 cases. Histopathology 69:459–469. https://doi.org/10.1111/his.12943CrossRefPubMed Yamada Y, Yamamoto H, Kohashi K, Ishii T, Iura K, Maekawa A, Bekki H, Otsuka H, Yamashita K, Tanaka H, Hiraki T, Mukai M, Shirakawa A, Shinnou Y, Jinno M, Yanai H, Taguchi K, Maehara Y, Iwamoto Y, Oda Y (2016) Histological spectrum of angiofibroma of soft tissue: histological and genetic analysis of 13 cases. Histopathology 69:459–469. https://​doi.​org/​10.​1111/​his.​12943CrossRefPubMed

go back to reference Jin Y, Moller E, Nord KH, Mandahl N, Von Steyern FV, Domanski HA, Marino-Enriquez A, Magnusson L, Nilsson J, Sciot R, Fletcher CD, Debiec-Rychter M, Mertens F (2012) Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes. Genes Chromosomes Cancer 51:510–520. https://doi.org/10.1002/gcc.21939CrossRefPubMed Jin Y, Moller E, Nord KH, Mandahl N, Von Steyern FV, Domanski HA, Marino-Enriquez A, Magnusson L, Nilsson J, Sciot R, Fletcher CD, Debiec-Rychter M, Mertens F (2012) Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes. Genes Chromosomes Cancer 51:510–520. https://​doi.​org/​10.​1002/​gcc.​21939CrossRefPubMed

go back to reference Tannenbaum-Dvir S, Glade Bender JL, Church AJ, Janeway KA, Harris MH, Mansukhani MM, Nagy PL, Andrews SJ, Murty VV, Kadenhe-Chiweshe A, Connolly EP, Kung AL, Dela Cruz FS (2015) Characterization of a novel fusion gene EML4-NTRK3 in a case of recurrent congenital fibrosarcoma. Cold Spring Harb Mol Case Stud 1:a000471. https://doi.org/10.1101/mcs.a000471CrossRefPubMedPubMedCentral Tannenbaum-Dvir S, Glade Bender JL, Church AJ, Janeway KA, Harris MH, Mansukhani MM, Nagy PL, Andrews SJ, Murty VV, Kadenhe-Chiweshe A, Connolly EP, Kung AL, Dela Cruz FS (2015) Characterization of a novel fusion gene EML4-NTRK3 in a case of recurrent congenital fibrosarcoma. Cold Spring Harb Mol Case Stud 1:a000471. https://​doi.​org/​10.​1101/​mcs.​a000471CrossRefPubMedPubMedCentral

go back to reference Church AJ, Calicchio ML, Nardi V, Skalova A, Pinto A, Dillon DA, Gomez-Fernandez CR, Manoj N, Haimes JD, Stahl JA, Dela Cruz FS, Tannenbaum-Dvir S, Glade-Bender JL, Kung AL, DuBois SG, Kozakewich HP, Janeway KA, Perez-Atayde AR, Harris MH (2018) Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy. Mod Pathol 31:463–473. https://doi.org/10.1038/modpathol.2017.127CrossRefPubMed Church AJ, Calicchio ML, Nardi V, Skalova A, Pinto A, Dillon DA, Gomez-Fernandez CR, Manoj N, Haimes JD, Stahl JA, Dela Cruz FS, Tannenbaum-Dvir S, Glade-Bender JL, Kung AL, DuBois SG, Kozakewich HP, Janeway KA, Perez-Atayde AR, Harris MH (2018) Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy. Mod Pathol 31:463–473. https://​doi.​org/​10.​1038/​modpathol.​2017.​127CrossRefPubMed

go back to reference Bender J, Anderson B, Bloom DA, Rabah R, McDougall R, Vats P, Mody R (2019) Refractory and metastatic infantile fibrosarcoma harboring LMNA-NTRK1 fusion shows complete and durable response to crizotinib. Cold Spring Harb Mol Case Stud 5. https://doi.org/10.1101/mcs.a003376 Bender J, Anderson B, Bloom DA, Rabah R, McDougall R, Vats P, Mody R (2019) Refractory and metastatic infantile fibrosarcoma harboring LMNA-NTRK1 fusion shows complete and durable response to crizotinib. Cold Spring Harb Mol Case Stud 5. https://​doi.​org/​10.​1101/​mcs.​a003376

go back to reference Kao YC, Fletcher CDM, Alaggio R, Wexler L, Zhang L, Sung YS, Orhan D, Chang WC, Swanson D, Dickson BC, Antonescu CR (2018) Recurrent BRAF gene fusions in a subset of pediatric spindle cell sarcomas: expanding the genetic spectrum of tumors with overlapping features with infantile fibrosarcoma. Am J Surg Pathol 42:28–38. https://doi.org/10.1097/PAS.0000000000000938CrossRefPubMedPubMedCentral Kao YC, Fletcher CDM, Alaggio R, Wexler L, Zhang L, Sung YS, Orhan D, Chang WC, Swanson D, Dickson BC, Antonescu CR (2018) Recurrent BRAF gene fusions in a subset of pediatric spindle cell sarcomas: expanding the genetic spectrum of tumors with overlapping features with infantile fibrosarcoma. Am J Surg Pathol 42:28–38. https://​doi.​org/​10.​1097/​PAS.​0000000000000938​CrossRefPubMedPubMedCentral

go back to reference Wegert J, Vokuhl C, Collord G, Del Castillo V-HM, Farndon SJ, Guzzo C, Jorgensen M, Anderson J, Slater O, Duncan C, Bausenwein S, Streitenberger H, Ziegler B, Furtwangler R, Graf N, Stratton MR, Campbell PJ, Jones DT, Koelsche C, Pfister SM, Mifsud W, Sebire N, Sparber-Sauer M, Koscielniak E, Rosenwald A, Gessler M, Behjati S (2018) Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants. Nat Commun 9:2378. https://doi.org/10.1038/s41467-018-04650-6CrossRefPubMedPubMedCentral Wegert J, Vokuhl C, Collord G, Del Castillo V-HM, Farndon SJ, Guzzo C, Jorgensen M, Anderson J, Slater O, Duncan C, Bausenwein S, Streitenberger H, Ziegler B, Furtwangler R, Graf N, Stratton MR, Campbell PJ, Jones DT, Koelsche C, Pfister SM, Mifsud W, Sebire N, Sparber-Sauer M, Koscielniak E, Rosenwald A, Gessler M, Behjati S (2018) Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants. Nat Commun 9:2378. https://​doi.​org/​10.​1038/​s41467-018-04650-6CrossRefPubMedPubMedCentral

go back to reference Suurmeijer AJH, Dickson BC, Swanson D, Zhang L, Sung YS, Cotzia P, Fletcher CDM, Antonescu CR (2018) A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes. Genes Chromosomes Cancer 57:611–621. https://doi.org/10.1002/gcc.22671CrossRefPubMedPubMedCentral Suurmeijer AJH, Dickson BC, Swanson D, Zhang L, Sung YS, Cotzia P, Fletcher CDM, Antonescu CR (2018) A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes. Genes Chromosomes Cancer 57:611–621. https://​doi.​org/​10.​1002/​gcc.​22671CrossRefPubMedPubMedCentral

go back to reference Agaram NP, Zhang L, Sung YS, Chen CL, Chung CT, Antonescu CR, Fletcher CD (2016) Recurrent NTRK1 gene fusions define a novel subset of locally aggressive lipofibromatosis-like neural tumors. Am J Surg Pathol 40:1407–1416. https://doi.org/10.1097/PAS.0000000000000675CrossRefPubMedPubMedCentral Agaram NP, Zhang L, Sung YS, Chen CL, Chung CT, Antonescu CR, Fletcher CD (2016) Recurrent NTRK1 gene fusions define a novel subset of locally aggressive lipofibromatosis-like neural tumors. Am J Surg Pathol 40:1407–1416. https://​doi.​org/​10.​1097/​PAS.​0000000000000675​CrossRefPubMedPubMedCentral

go back to reference Yamazaki F, Nakatani F, Asano N, Wakai S, Sekimizu M, Mitani S, Kubo T, Kawai A, Ichikawa H, Yoshida A (2019) Novel NTRK3 fusions in fibrosarcomas of adults. Am J Surg Pathol 43:523–530. https://doi.org/10.1097/PAS.0000000000001194CrossRefPubMed Yamazaki F, Nakatani F, Asano N, Wakai S, Sekimizu M, Mitani S, Kubo T, Kawai A, Ichikawa H, Yoshida A (2019) Novel NTRK3 fusions in fibrosarcomas of adults. Am J Surg Pathol 43:523–530. https://​doi.​org/​10.​1097/​PAS.​0000000000001194​CrossRefPubMed

go back to reference Croce S, Hostein I, Longacre TA, Mills AM, Perot G, Devouassoux-Shisheboran M, Velasco V, Floquet A, Guyon F, Chakiba C, Querleu D, Khalifa E, Mayeur L, Rebier F, Leguellec S, Soubeyran I, McCluggage WG (2019) Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasms. Mod Pathol. 32:1008–1022. https://doi.org/10.1038/s41379-018-0184-6CrossRefPubMed Croce S, Hostein I, Longacre TA, Mills AM, Perot G, Devouassoux-Shisheboran M, Velasco V, Floquet A, Guyon F, Chakiba C, Querleu D, Khalifa E, Mayeur L, Rebier F, Leguellec S, Soubeyran I, McCluggage WG (2019) Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasms. Mod Pathol. 32:1008–1022. https://​doi.​org/​10.​1038/​s41379-018-0184-6CrossRefPubMed

go back to reference Chiang S, Cotzia P, Hyman DM, Drilon A, Tap WD, Zhang L, Hechtman JF, Frosina D, Jungbluth AA, Murali R, Park KJ, Soslow RA, Oliva E, Iafrate AJ, Benayed R, Ladanyi M, Antonescu CR (2018) NTRK fusions define a novel uterine sarcoma subtype with features of fibrosarcoma. Am J Surg Pathol 42:791–798. https://doi.org/10.1097/PAS.0000000000001055CrossRefPubMedPubMedCentral Chiang S, Cotzia P, Hyman DM, Drilon A, Tap WD, Zhang L, Hechtman JF, Frosina D, Jungbluth AA, Murali R, Park KJ, Soslow RA, Oliva E, Iafrate AJ, Benayed R, Ladanyi M, Antonescu CR (2018) NTRK fusions define a novel uterine sarcoma subtype with features of fibrosarcoma. Am J Surg Pathol 42:791–798. https://​doi.​org/​10.​1097/​PAS.​0000000000001055​CrossRefPubMedPubMedCentral

go back to reference Haller F, Knopf J, Ackermann A, Bieg M, Kleinheinz K, Schlesner M, Moskalev EA, Will R, Satir AA, Abdelmagid IE, Giedl J, Carbon R, Rompel O, Hartmann A, Wiemann S, Metzler M, Agaimy A (2016) Paediatric and adult soft tissue sarcomas with NTRK1 gene fusions: a subset of spindle cell sarcomas unified by a prominent myopericytic/haemangiopericytic pattern. J Pathol 238:700–710. https://doi.org/10.1002/path.4701CrossRefPubMed Haller F, Knopf J, Ackermann A, Bieg M, Kleinheinz K, Schlesner M, Moskalev EA, Will R, Satir AA, Abdelmagid IE, Giedl J, Carbon R, Rompel O, Hartmann A, Wiemann S, Metzler M, Agaimy A (2016) Paediatric and adult soft tissue sarcomas with NTRK1 gene fusions: a subset of spindle cell sarcomas unified by a prominent myopericytic/haemangiopericytic pattern. J Pathol 238:700–710. https://​doi.​org/​10.​1002/​path.​4701CrossRefPubMed

go back to reference Hechtman JF, Benayed R, Hyman DM, Drilon A, Zehir A, Frosina D, Arcila ME, Dogan S, Klimstra DS, Ladanyi M, Jungbluth AA (2017) Pan-Trk immunohistochemistry is an efficient and reliable screen for the detection of NTRK fusions. Am J Surg Pathol 41:1547–1551. https://doi.org/10.1097/PAS.0000000000000911CrossRefPubMedPubMedCentral Hechtman JF, Benayed R, Hyman DM, Drilon A, Zehir A, Frosina D, Arcila ME, Dogan S, Klimstra DS, Ladanyi M, Jungbluth AA (2017) Pan-Trk immunohistochemistry is an efficient and reliable screen for the detection of NTRK fusions. Am J Surg Pathol 41:1547–1551. https://​doi.​org/​10.​1097/​PAS.​0000000000000911​CrossRefPubMedPubMedCentral

go back to reference Rudzinski ER, Lockwood CM, Stohr BA, Vargas SO, Sheridan R, Black JO, Rajaram V, Laetsch TW, Davis JL (2018) Pan-Trk immunohistochemistry identifies NTRK rearrangements in pediatric mesenchymal tumors. Am J Surg Pathol 42:927–935. https://doi.org/10.1097/PAS.0000000000001062CrossRefPubMed Rudzinski ER, Lockwood CM, Stohr BA, Vargas SO, Sheridan R, Black JO, Rajaram V, Laetsch TW, Davis JL (2018) Pan-Trk immunohistochemistry identifies NTRK rearrangements in pediatric mesenchymal tumors. Am J Surg Pathol 42:927–935. https://​doi.​org/​10.​1097/​PAS.​0000000000001062​CrossRefPubMed

go back to reference Hung YP, Fletcher CDM, Hornick JL (2018) Evaluation of pan-Trk immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics. Histopathology 73:634–644. https://doi.org/10.1111/his.13666CrossRefPubMed Hung YP, Fletcher CDM, Hornick JL (2018) Evaluation of pan-Trk immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics. Histopathology 73:634–644. https://​doi.​org/​10.​1111/​his.​13666CrossRefPubMed

go back to reference DuBois SG, Laetsch TW, Federman N, Turpin BK, Albert CM, Nagasubramanian R, Anderson ME, Davis JL, Qamoos HE, Reynolds ME, Cruickshank S, Cox MC, Hawkins DS, Mascarenhas L, Pappo AS (2018) The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas. Cancer 124:4241–4247. https://doi.org/10.1002/cncr.31701CrossRefPubMed DuBois SG, Laetsch TW, Federman N, Turpin BK, Albert CM, Nagasubramanian R, Anderson ME, Davis JL, Qamoos HE, Reynolds ME, Cruickshank S, Cox MC, Hawkins DS, Mascarenhas L, Pappo AS (2018) The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas. Cancer 124:4241–4247. https://​doi.​org/​10.​1002/​cncr.​31701CrossRefPubMed

go back to reference Laetsch TW, DuBois SG, Mascarenhas L, Turpin B, Federman N, Albert CM, Nagasubramanian R, Davis JL, Rudzinski E, Feraco AM, Tuch BB, Ebata KT, Reynolds M, Smith S, Cruickshank S, Cox MC, Pappo AS, Hawkins DS (2018) Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study. Lancet Oncol 19:705–714. https://doi.org/10.1016/S1470-2045(18)30119-0CrossRefPubMedPubMedCentral Laetsch TW, DuBois SG, Mascarenhas L, Turpin B, Federman N, Albert CM, Nagasubramanian R, Davis JL, Rudzinski E, Feraco AM, Tuch BB, Ebata KT, Reynolds M, Smith S, Cruickshank S, Cox MC, Pappo AS, Hawkins DS (2018) Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study. Lancet Oncol 19:705–714. https://​doi.​org/​10.​1016/​S1470-2045(18)30119-0CrossRefPubMedPubMedCentral

go back to reference Montgomery EA, Devaney KO, Giordano TJ, Weiss SW (1998) Inflammatory myxohyaline tumor of distal extremities with virocyte or Reed-Sternberg-like cells: a distinctive lesion with features simulating inflammatory conditions, Hodgkin’s disease, and various sarcomas. Mod Pathol 11:384–391PubMed Montgomery EA, Devaney KO, Giordano TJ, Weiss SW (1998) Inflammatory myxohyaline tumor of distal extremities with virocyte or Reed-Sternberg-like cells: a distinctive lesion with features simulating inflammatory conditions, Hodgkin’s disease, and various sarcomas. Mod Pathol 11:384–391PubMed

go back to reference Boland JM, Folpe AL (2017) Hemosiderotic fibrolipomatous tumor, pleomorphic hyalinizing angiectatic tumor, and myxoinflammatory fibroblastic sarcoma: related or not? Adv Anat Pathol 24:268–277. https://doi.org/10.1097/PAP.0000000000000151CrossRefPubMed Boland JM, Folpe AL (2017) Hemosiderotic fibrolipomatous tumor, pleomorphic hyalinizing angiectatic tumor, and myxoinflammatory fibroblastic sarcoma: related or not? Adv Anat Pathol 24:268–277. https://​doi.​org/​10.​1097/​PAP.​0000000000000151​CrossRefPubMed

go back to reference Hallor KH, Sciot R, Staaf J, Heidenblad M, Rydholm A, Bauer HC, Astrom K, Domanski HA, Meis JM, Kindblom LG, Panagopoulos I, Mandahl N, Mertens F (2009) Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions. J Pathol 217:716–727. https://doi.org/10.1002/path.2513CrossRefPubMed Hallor KH, Sciot R, Staaf J, Heidenblad M, Rydholm A, Bauer HC, Astrom K, Domanski HA, Meis JM, Kindblom LG, Panagopoulos I, Mandahl N, Mertens F (2009) Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions. J Pathol 217:716–727. https://​doi.​org/​10.​1002/​path.​2513CrossRefPubMed

go back to reference Liu H, Sukov WR, Ro JY (2019) The t(1;10)(p22;q24) TGFBR3/MGEA5 translocation in pleomorphic hyalinizing angiectatic tumor, myxoinflammatory fibroblastic sarcoma, and hemosiderotic fibrolipomatous tumor. Arch Pathol Lab Med 143:212–221. https://doi.org/10.5858/arpa.2017-0412-RACrossRefPubMed Liu H, Sukov WR, Ro JY (2019) The t(1;10)(p22;q24) TGFBR3/MGEA5 translocation in pleomorphic hyalinizing angiectatic tumor, myxoinflammatory fibroblastic sarcoma, and hemosiderotic fibrolipomatous tumor. Arch Pathol Lab Med 143:212–221. https://​doi.​org/​10.​5858/​arpa.​2017-0412-RACrossRefPubMed

go back to reference Antonescu CR, Zhang L, Nielsen GP, Rosenberg AE, Dal Cin P, Fletcher CD (2011) Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor. Genes Chromosomes Cancer 50:757–764. https://doi.org/10.1002/gcc.20897CrossRefPubMedPubMedCentral Antonescu CR, Zhang L, Nielsen GP, Rosenberg AE, Dal Cin P, Fletcher CD (2011) Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor. Genes Chromosomes Cancer 50:757–764. https://​doi.​org/​10.​1002/​gcc.​20897CrossRefPubMedPubMedCentral

go back to reference Laskin WB, Fetsch JF, Miettinen M (2014) Myxoinflammatory fibroblastic sarcoma: a clinicopathologic analysis of 104 cases, with emphasis on predictors of outcome. Am J Surg Pathol 38:1–12. https://doi.org/10.1097/PAS.0b013e31829f3d85CrossRefPubMedPubMedCentral Laskin WB, Fetsch JF, Miettinen M (2014) Myxoinflammatory fibroblastic sarcoma: a clinicopathologic analysis of 104 cases, with emphasis on predictors of outcome. Am J Surg Pathol 38:1–12. https://​doi.​org/​10.​1097/​PAS.​0b013e31829f3d85​CrossRefPubMedPubMedCentral

go back to reference Carter JM, Sukov WR, Montgomery E, Goldblum JR, Billings SD, Fritchie KJ, Folpe AL (2014) TGFBR3 and MGEA5 rearrangements in pleomorphic hyalinizing angiectatic tumors and the spectrum of related neoplasms. Am J Surg Pathol 38:1182–1992. https://doi.org/10.1097/PAS.0000000000000212CrossRefPubMed Carter JM, Sukov WR, Montgomery E, Goldblum JR, Billings SD, Fritchie KJ, Folpe AL (2014) TGFBR3 and MGEA5 rearrangements in pleomorphic hyalinizing angiectatic tumors and the spectrum of related neoplasms. Am J Surg Pathol 38:1182–1992. https://​doi.​org/​10.​1097/​PAS.​0000000000000212​CrossRefPubMed

go back to reference Michal M, Kazakov DV, Hadravsky L, Agaimy A, Svajdler M, Kuroda N, Michal M (2016) Pleomorphic hyalinizing angiectatic tumor revisited: all tumors manifest typical morphologic features of myxoinflammatory fibroblastic sarcoma, further suggesting 2 morphologic variants of a single entity. Ann Diagn Pathol 20:40–43. https://doi.org/10.1016/j.anndiagpath.2015.10.006CrossRefPubMed Michal M, Kazakov DV, Hadravsky L, Agaimy A, Svajdler M, Kuroda N, Michal M (2016) Pleomorphic hyalinizing angiectatic tumor revisited: all tumors manifest typical morphologic features of myxoinflammatory fibroblastic sarcoma, further suggesting 2 morphologic variants of a single entity. Ann Diagn Pathol 20:40–43. https://​doi.​org/​10.​1016/​j.​anndiagpath.​2015.​10.​006CrossRefPubMed

go back to reference Network CGAR (2017) Comprehensive and integrated genomic characterization of adult soft tissue sarcomas. Cell 171:950–965 e928CrossRef Network CGAR (2017) Comprehensive and integrated genomic characterization of adult soft tissue sarcomas. Cell 171:950–965 e928CrossRef

go back to reference Kao YC, Ranucci V, Zhang L, Sung YS, Athanasian EA, Swanson D, Dickson BC, Antonescu CR (2017) Recurrent BRAF gene rearrangements in myxoinflammatory fibroblastic sarcomas, but not hemosiderotic fibrolipomatous tumors. Am J Surg Pathol 41:1456–1465. https://doi.org/10.1097/PAS.0000000000000899CrossRefPubMedPubMedCentral Kao YC, Ranucci V, Zhang L, Sung YS, Athanasian EA, Swanson D, Dickson BC, Antonescu CR (2017) Recurrent BRAF gene rearrangements in myxoinflammatory fibroblastic sarcomas, but not hemosiderotic fibrolipomatous tumors. Am J Surg Pathol 41:1456–1465. https://​doi.​org/​10.​1097/​PAS.​0000000000000899​CrossRefPubMedPubMedCentral

go back to reference Guillou L, Benhattar J, Gengler C, Gallagher G, Ranchere-Vince D, Collin F, Terrier P, Terrier-Lacombe MJ, Leroux A, Marques B, Aubain Somerhausen Nde S, Keslair F, Pedeutour F, Coindre JM (2007) Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group. Am J Surg Pathol 31:1387–1402. https://doi.org/10.1097/PAS.0b013e3180321959CrossRefPubMed Guillou L, Benhattar J, Gengler C, Gallagher G, Ranchere-Vince D, Collin F, Terrier P, Terrier-Lacombe MJ, Leroux A, Marques B, Aubain Somerhausen Nde S, Keslair F, Pedeutour F, Coindre JM (2007) Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group. Am J Surg Pathol 31:1387–1402. https://​doi.​org/​10.​1097/​PAS.​0b013e3180321959​CrossRefPubMed

go back to reference Rekhi B, Deshmukh M, Jambhekar NA (2011) Low-grade fibromyxoid sarcoma: a clinicopathologic study of 18 cases, including histopathologic relationship with sclerosing epithelioid fibrosarcoma in a subset of cases. Ann Diagn Pathol 15:303–311. https://doi.org/10.1016/j.anndiagpath.2011.02.005CrossRefPubMed Rekhi B, Deshmukh M, Jambhekar NA (2011) Low-grade fibromyxoid sarcoma: a clinicopathologic study of 18 cases, including histopathologic relationship with sclerosing epithelioid fibrosarcoma in a subset of cases. Ann Diagn Pathol 15:303–311. https://​doi.​org/​10.​1016/​j.​anndiagpath.​2011.​02.​005CrossRefPubMed

go back to reference Mohamed M, Fisher C, Thway K (2017) Low-grade fibromyxoid sarcoma: Clinical, morphologic and genetic features. Ann Diagn Pathol 28:60–67. https://doi.org/10.1016/j.anndiagpath.2017.04.001CrossRefPubMed Mohamed M, Fisher C, Thway K (2017) Low-grade fibromyxoid sarcoma: Clinical, morphologic and genetic features. Ann Diagn Pathol 28:60–67. https://​doi.​org/​10.​1016/​j.​anndiagpath.​2017.​04.​001CrossRefPubMed

go back to reference Antonescu CR, Rosenblum MK, Pereira P, Nascimento AG, Woodruff JM (2001) Sclerosing epithelioid fibrosarcoma: a study of 16 cases and confirmation of a clinicopathologically distinct tumor. Am J Surg Pathol 25:699–709CrossRef Antonescu CR, Rosenblum MK, Pereira P, Nascimento AG, Woodruff JM (2001) Sclerosing epithelioid fibrosarcoma: a study of 16 cases and confirmation of a clinicopathologically distinct tumor. Am J Surg Pathol 25:699–709CrossRef

go back to reference Arbajian E, Puls F, Magnusson L, Thway K, Fisher C, Sumathi VP, Tayebwa J, Nord KH, Kindblom LG, Mertens F (2014) Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma. Am J Surg Pathol 38:801–808. https://doi.org/10.1097/PAS.0000000000000158CrossRefPubMed Arbajian E, Puls F, Magnusson L, Thway K, Fisher C, Sumathi VP, Tayebwa J, Nord KH, Kindblom LG, Mertens F (2014) Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma. Am J Surg Pathol 38:801–808. https://​doi.​org/​10.​1097/​PAS.​0000000000000158​CrossRefPubMed

go back to reference Wang WL, Evans HL, Meis JM, Liegl-Atzwanger B, Bovee JV, Goldblum JR, Billings SD, Rubin BP, Lopez-Terrada D, Lazar AJ (2012) FUS rearrangements are rare in ʻpure’ sclerosing epithelioid fibrosarcoma. Mod Pathol 25:846–853. https://doi.org/10.1038/modpathol.2011.214CrossRefPubMed Wang WL, Evans HL, Meis JM, Liegl-Atzwanger B, Bovee JV, Goldblum JR, Billings SD, Rubin BP, Lopez-Terrada D, Lazar AJ (2012) FUS rearrangements are rare in ʻpure’ sclerosing epithelioid fibrosarcoma. Mod Pathol 25:846–853. https://​doi.​org/​10.​1038/​modpathol.​2011.​214CrossRefPubMed

go back to reference Stockman DL, Ali SM, He J, Ross JS, Meis JM (2014) Sclerosing epithelioid fibrosarcoma presenting as intraabdominal sarcomatosis with a novel EWSR1-CREB3L1 gene fusion. Hum Pathol 45:2173–2178. https://doi.org/10.1016/j.humpath.2014.05.006CrossRefPubMed Stockman DL, Ali SM, He J, Ross JS, Meis JM (2014) Sclerosing epithelioid fibrosarcoma presenting as intraabdominal sarcomatosis with a novel EWSR1-CREB3L1 gene fusion. Hum Pathol 45:2173–2178. https://​doi.​org/​10.​1016/​j.​humpath.​2014.​05.​006CrossRefPubMed

go back to reference Lau PP, Lui PC, Lau GT, Yau DT, Cheung ET, Chan JK (2013) EWSR1-CREB3L1 gene fusion: a novel alternative molecular aberration of low-grade fibromyxoid sarcoma. Am J Surg Pathol 37:734–738. https://doi.org/10.1097/PAS.0b013e31827560f8CrossRefPubMed Lau PP, Lui PC, Lau GT, Yau DT, Cheung ET, Chan JK (2013) EWSR1-CREB3L1 gene fusion: a novel alternative molecular aberration of low-grade fibromyxoid sarcoma. Am J Surg Pathol 37:734–738. https://​doi.​org/​10.​1097/​PAS.​0b013e31827560f8​CrossRefPubMed

go back to reference Dewaele B, Libbrecht L, Levy G, Brichard B, Vanspauwen V, Sciot R, Debiec-Rychter M (2017) A novel EWS-CREB3L3 gene fusion in a mesenteric sclerosing epithelioid fibrosarcoma. Genes Chromosomes Cancer 56:695–699. https://doi.org/10.1002/gcc.22474CrossRefPubMed Dewaele B, Libbrecht L, Levy G, Brichard B, Vanspauwen V, Sciot R, Debiec-Rychter M (2017) A novel EWS-CREB3L3 gene fusion in a mesenteric sclerosing epithelioid fibrosarcoma. Genes Chromosomes Cancer 56:695–699. https://​doi.​org/​10.​1002/​gcc.​22474CrossRefPubMed

go back to reference Dong F, Quade BJ, Dal Cin P, Jo VY (2018) Expanding the spectrum of translocations in sclerosing epitheloid fibrosarcoma: a new case with EWSR1-CREB3L3 fusion. Genes Chromosomes Cancer 57:675–677. https://doi.org/10.1002/gcc.22677CrossRefPubMed Dong F, Quade BJ, Dal Cin P, Jo VY (2018) Expanding the spectrum of translocations in sclerosing epitheloid fibrosarcoma: a new case with EWSR1-CREB3L3 fusion. Genes Chromosomes Cancer 57:675–677. https://​doi.​org/​10.​1002/​gcc.​22677CrossRefPubMed

go back to reference Arbajian E, Puls F, Antonescu CR, Amary F, Sciot R, Debiec-Rychter M, Sumathi VP, Jaras M, Magnusson L, Nilsson J, Hofvander J, Mertens F (2017) In-depth genetic analysis of sclerosing epithelioid fibrosarcoma reveals recurrent genomic alterations and potential treatment targets. Clin Cancer Res 23:7426–7434. https://doi.org/10.1158/1078-0432.CCR-17-1856CrossRefPubMed Arbajian E, Puls F, Antonescu CR, Amary F, Sciot R, Debiec-Rychter M, Sumathi VP, Jaras M, Magnusson L, Nilsson J, Hofvander J, Mertens F (2017) In-depth genetic analysis of sclerosing epithelioid fibrosarcoma reveals recurrent genomic alterations and potential treatment targets. Clin Cancer Res 23:7426–7434. https://​doi.​org/​10.​1158/​1078-0432.​CCR-17-1856CrossRefPubMed

go back to reference Robinson DR, Wu YM, Kalyana-Sundaram S, Cao X, Lonigro RJ, Sung YS, Chen CL, Zhang L, Wang R, Su F, Iyer MK, Roychowdhury S, Siddiqui J, Pienta KJ, Kunju LP, Talpaz M, Mosquera JM, Singer S, Schuetze SM, Antonescu CR, Chinnaiyan AM (2013) Identification of recurrent NAB2–STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nat Genet 45:180–185. https://doi.org/10.1038/ng.2509CrossRefPubMedPubMedCentral Robinson DR, Wu YM, Kalyana-Sundaram S, Cao X, Lonigro RJ, Sung YS, Chen CL, Zhang L, Wang R, Su F, Iyer MK, Roychowdhury S, Siddiqui J, Pienta KJ, Kunju LP, Talpaz M, Mosquera JM, Singer S, Schuetze SM, Antonescu CR, Chinnaiyan AM (2013) Identification of recurrent NAB2–STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nat Genet 45:180–185. https://​doi.​org/​10.​1038/​ng.​2509CrossRefPubMedPubMedCentral

go back to reference Chmielecki J, Crago AM, Rosenberg M, O’Connor R, Walker SR, Ambrogio L, Auclair D, McKenna A, Heinrich MC, Frank DA, Meyerson M (2013) Whole-exome sequencing identifies a recurrent NAB2–STAT6 fusion in solitary fibrous tumors. Nat Genet 45:131–132. https://doi.org/10.1038/ng.2522CrossRefPubMedPubMedCentral Chmielecki J, Crago AM, Rosenberg M, O’Connor R, Walker SR, Ambrogio L, Auclair D, McKenna A, Heinrich MC, Frank DA, Meyerson M (2013) Whole-exome sequencing identifies a recurrent NAB2–STAT6 fusion in solitary fibrous tumors. Nat Genet 45:131–132. https://​doi.​org/​10.​1038/​ng.​2522CrossRefPubMedPubMedCentral

go back to reference Koelsche C, Schweizer L, Renner M, Warth A, Jones DT, Sahm F, Reuss DE, Capper D, Knosel T, Schulz B, Petersen I, Ulrich A, Renker EK, Lehner B, Pfister SM, Schirmacher P, von Deimling A, Mechtersheimer G (2014) Nuclear relocation of STAT6 reliably predicts NAB2–STAT6 fusion for the diagnosis of solitary fibrous tumour. Histopathology 65:613–622. https://doi.org/10.1111/his.12431CrossRefPubMed Koelsche C, Schweizer L, Renner M, Warth A, Jones DT, Sahm F, Reuss DE, Capper D, Knosel T, Schulz B, Petersen I, Ulrich A, Renker EK, Lehner B, Pfister SM, Schirmacher P, von Deimling A, Mechtersheimer G (2014) Nuclear relocation of STAT6 reliably predicts NAB2–STAT6 fusion for the diagnosis of solitary fibrous tumour. Histopathology 65:613–622. https://​doi.​org/​10.​1111/​his.​12431CrossRefPubMed

go back to reference Doyle LA, Vivero M, Fletcher CD, Mertens F, Hornick JL (2014) Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Mod Pathol 27:390–395. https://doi.org/10.1038/modpathol.2013.164CrossRefPubMed Doyle LA, Vivero M, Fletcher CD, Mertens F, Hornick JL (2014) Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Mod Pathol 27:390–395. https://​doi.​org/​10.​1038/​modpathol.​2013.​164CrossRefPubMed

go back to reference Demicco EG, Harms PW, Patel RM, Smith SC, Ingram D, Torres K, Carskadon SL, Camelo-Piragua S, McHugh JB, Siddiqui J, Palanisamy N, Lucas DR, Lazar AJ, Wang WL (2015) Extensive survey of STAT6 expression in a large series of mesenchymal tumors. Am J Clin Pathol 143:672–682. https://doi.org/10.1309/AJCPN25NJTOUNPNFCrossRefPubMed Demicco EG, Harms PW, Patel RM, Smith SC, Ingram D, Torres K, Carskadon SL, Camelo-Piragua S, McHugh JB, Siddiqui J, Palanisamy N, Lucas DR, Lazar AJ, Wang WL (2015) Extensive survey of STAT6 expression in a large series of mesenchymal tumors. Am J Clin Pathol 143:672–682. https://​doi.​org/​10.​1309/​AJCPN25NJTOUNPNF​CrossRefPubMed

go back to reference Demicco EG, Wani K, Ingram D, Wagner M, Maki RG, Rizzo A, Meeker A, Lazar AJ, Wang WL (2018) TERT promoter mutations in solitary fibrous tumour. Histopathology 73:843–851. https://doi.org/10.1111/his.13703CrossRefPubMed Demicco EG, Wani K, Ingram D, Wagner M, Maki RG, Rizzo A, Meeker A, Lazar AJ, Wang WL (2018) TERT promoter mutations in solitary fibrous tumour. Histopathology 73:843–851. https://​doi.​org/​10.​1111/​his.​13703CrossRefPubMed

go back to reference Lin Y, Seger N, Tsagkozis P, Hesla AC, Ghaderi M, Chen Y, Ehnman M, Warsito D, Wejde J, Larsson O, Haglund F (2018) Telomerase promoter mutations and copy number alterations in solitary fibrous tumours. J Clin Pathol 71:832–839. https://doi.org/10.1136/jclinpath-2018-205132CrossRefPubMed Lin Y, Seger N, Tsagkozis P, Hesla AC, Ghaderi M, Chen Y, Ehnman M, Warsito D, Wejde J, Larsson O, Haglund F (2018) Telomerase promoter mutations and copy number alterations in solitary fibrous tumours. J Clin Pathol 71:832–839. https://​doi.​org/​10.​1136/​jclinpath-2018-205132CrossRefPubMed

go back to reference Akaike K, Kurisaki-Arakawa A, Hara K, Suehara Y, Takagi T, Mitani K, Kaneko K, Yao T, Saito T (2015) Distinct clinicopathological features of NAB2–STAT6 fusion gene variants in solitary fibrous tumor with emphasis on the acquisition of highly malignant potential. Hum Pathol 46:347–356. https://doi.org/10.1016/j.humpath.2014.11.018CrossRefPubMed Akaike K, Kurisaki-Arakawa A, Hara K, Suehara Y, Takagi T, Mitani K, Kaneko K, Yao T, Saito T (2015) Distinct clinicopathological features of NAB2–STAT6 fusion gene variants in solitary fibrous tumor with emphasis on the acquisition of highly malignant potential. Hum Pathol 46:347–356. https://​doi.​org/​10.​1016/​j.​humpath.​2014.​11.​018CrossRefPubMed

go back to reference Bahrami A, Lee S, Schaefer IM, Boland JM, Patton KT, Pounds S, Fletcher CD (2016) TERT promoter mutations and prognosis in solitary fibrous tumor. Mod Pathol 29:1511–1522. https://doi.org/10.1038/modpathol.2016.126CrossRefPubMedPubMedCentral Bahrami A, Lee S, Schaefer IM, Boland JM, Patton KT, Pounds S, Fletcher CD (2016) TERT promoter mutations and prognosis in solitary fibrous tumor. Mod Pathol 29:1511–1522. https://​doi.​org/​10.​1038/​modpathol.​2016.​126CrossRefPubMedPubMedCentral

go back to reference Barthelmess S, Geddert H, Boltze C, Moskalev EA, Bieg M, Sirbu H, Brors B, Wiemann S, Hartmann A, Agaimy A, Haller F (2014) Solitary fibrous tumors/hemangiopericytomas with different variants of the NAB2–STAT6 gene fusion are characterized by specific histomorphology and distinct clinicopathological features. Am J Pathol 184:1209–1218. https://doi.org/10.1016/j.ajpath.2013.12.016CrossRefPubMed Barthelmess S, Geddert H, Boltze C, Moskalev EA, Bieg M, Sirbu H, Brors B, Wiemann S, Hartmann A, Agaimy A, Haller F (2014) Solitary fibrous tumors/hemangiopericytomas with different variants of the NAB2–STAT6 gene fusion are characterized by specific histomorphology and distinct clinicopathological features. Am J Pathol 184:1209–1218. https://​doi.​org/​10.​1016/​j.​ajpath.​2013.​12.​016CrossRefPubMed

go back to reference Tai HC, Chuang IC, Chen TC, Li CF, Huang SC, Kao YC, Lin PC, Tsai JW, Lan J, Yu SC, Yen SL, Jung SM, Liao KC, Fang FM, Huang HY (2015) NAB2–STAT6 fusion types account for clinicopathological variations in solitary fibrous tumors. Mod Pathol 28:1324–1335. https://doi.org/10.1038/modpathol.2015.90CrossRefPubMed Tai HC, Chuang IC, Chen TC, Li CF, Huang SC, Kao YC, Lin PC, Tsai JW, Lan J, Yu SC, Yen SL, Jung SM, Liao KC, Fang FM, Huang HY (2015) NAB2–STAT6 fusion types account for clinicopathological variations in solitary fibrous tumors. Mod Pathol 28:1324–1335. https://​doi.​org/​10.​1038/​modpathol.​2015.​90CrossRefPubMed

go back to reference Huang SC, Li CF, Kao YC, Chuang IC, Tai HC, Tsai JW, Yu SC, Huang HY, Lan J, Yen SL, Lin PC, Chen TC (2016) The clinicopathological significance of NAB2–STAT6 gene fusions in 52 cases of intrathoracic solitary fibrous tumors. Cancer Med 5:159–168. https://doi.org/10.1002/cam4.572CrossRefPubMed Huang SC, Li CF, Kao YC, Chuang IC, Tai HC, Tsai JW, Yu SC, Huang HY, Lan J, Yen SL, Lin PC, Chen TC (2016) The clinicopathological significance of NAB2–STAT6 gene fusions in 52 cases of intrathoracic solitary fibrous tumors. Cancer Med 5:159–168. https://​doi.​org/​10.​1002/​cam4.​572CrossRefPubMed

go back to reference Demicco EG, Park MS, Araujo DM, Fox PS, Bassett RL, Pollock RE, Lazar AJ, Wang WL (2012) Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model. Mod Pathol 25:1298–1306. https://doi.org/10.1038/modpathol.2012.83CrossRefPubMed Demicco EG, Park MS, Araujo DM, Fox PS, Bassett RL, Pollock RE, Lazar AJ, Wang WL (2012) Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model. Mod Pathol 25:1298–1306. https://​doi.​org/​10.​1038/​modpathol.​2012.​83CrossRefPubMed

go back to reference Demicco EG, Wagner MJ, Maki RG, Gupta V, Iofin I, Lazar AJ, Wang WL (2017) Risk assessment in solitary fibrous tumors: validation and refinement of a risk stratification model. Mod Pathol 30:1433–1442. https://doi.org/10.1038/modpathol.2017.54CrossRefPubMed Demicco EG, Wagner MJ, Maki RG, Gupta V, Iofin I, Lazar AJ, Wang WL (2017) Risk assessment in solitary fibrous tumors: validation and refinement of a risk stratification model. Mod Pathol 30:1433–1442. https://​doi.​org/​10.​1038/​modpathol.​2017.​54CrossRefPubMed

go back to reference Pasquali S, Gronchi A, Strauss D, Bonvalot S, Jeys L, Stacchiotti S, Hayes A, Honore C, Collini P, Renne SL, Alexander N, Grimer RJ, Callegaro D, Sumathi VP, Gourevitch D, Desai A (2016) Resectable extra-pleural and extra-meningeal solitary fibrous tumours: a multi-centre prognostic study. Eur J Surg Oncol 42:1064–1070. https://doi.org/10.1016/j.ejso.2016.01.023CrossRefPubMed Pasquali S, Gronchi A, Strauss D, Bonvalot S, Jeys L, Stacchiotti S, Hayes A, Honore C, Collini P, Renne SL, Alexander N, Grimer RJ, Callegaro D, Sumathi VP, Gourevitch D, Desai A (2016) Resectable extra-pleural and extra-meningeal solitary fibrous tumours: a multi-centre prognostic study. Eur J Surg Oncol 42:1064–1070. https://​doi.​org/​10.​1016/​j.​ejso.​2016.​01.​023CrossRefPubMed

go back to reference Salas S, Resseguier N, Blay JY, Le Cesne A, Italiano A, Chevreau C, Rosset P, Isambert N, Soulie P, Cupissol D, Delcambre C, Bay JO, Dubray-Longeras P, Krengli M, De Bari B, Villa S, Kaanders J, Torrente S, Pasquier D, Thariat JO, Myroslav L, Sole CV, Dincbas HF, Habboush JY, Zilli T, Dragan T, Khan RK, Ugurluer G, Cena T, Duffaud F, Penel N, Bertucci F, Ranchere-Vince D, Terrier P, Bonvalot S, Macagno N, Lemoine C, Lae M, Coindre JM, Bouvier C (2017) Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database. Ann Oncol 28:1979–1987. https://doi.org/10.1093/annonc/mdx250CrossRefPubMed Salas S, Resseguier N, Blay JY, Le Cesne A, Italiano A, Chevreau C, Rosset P, Isambert N, Soulie P, Cupissol D, Delcambre C, Bay JO, Dubray-Longeras P, Krengli M, De Bari B, Villa S, Kaanders J, Torrente S, Pasquier D, Thariat JO, Myroslav L, Sole CV, Dincbas HF, Habboush JY, Zilli T, Dragan T, Khan RK, Ugurluer G, Cena T, Duffaud F, Penel N, Bertucci F, Ranchere-Vince D, Terrier P, Bonvalot S, Macagno N, Lemoine C, Lae M, Coindre JM, Bouvier C (2017) Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database. Ann Oncol 28:1979–1987. https://​doi.​org/​10.​1093/​annonc/​mdx250CrossRefPubMed

go back to reference Friis RB, Safwat A, Baad-Hansen T, Aggerholm-Pedersen N (2018) Solitary fibrous tumour: a single institution retrospective study and further validation of a prognostic risk assessment system. Clin Oncol (R Coll Radiol) 30:798–804. https://doi.org/10.1016/j.clon.2018.08.015CrossRef Friis RB, Safwat A, Baad-Hansen T, Aggerholm-Pedersen N (2018) Solitary fibrous tumour: a single institution retrospective study and further validation of a prognostic risk assessment system. Clin Oncol (R Coll Radiol) 30:798–804. https://​doi.​org/​10.​1016/​j.​clon.​2018.​08.​015CrossRef

go back to reference Demicco EG, Griffin AM, Gladdy RA, Dickson BC, Ferguson PC, Swallow CJ, Wunder JS, Wang WL (2019) Comparison of published risk models to predict outcome in extrameningeal solitary fibrous tumor. Histopathology. https://doi.org/10.1111/his.13940 Demicco EG, Griffin AM, Gladdy RA, Dickson BC, Ferguson PC, Swallow CJ, Wunder JS, Wang WL (2019) Comparison of published risk models to predict outcome in extrameningeal solitary fibrous tumor. Histopathology. https://​doi.​org/​10.​1111/​his.​13940

go back to reference Lee AY, Agaram NP, Qin LX, Kuk D, Curtin C, Brennan MF, Singer S (2016) Optimal percent myxoid component to predict outcome in high-grade myxofibrosarcoma and undifferentiated pleomorphic sarcoma. Ann Surg Oncol 23:818–825. https://doi.org/10.1245/s10434-015-5063-5CrossRefPubMedPubMedCentral Lee AY, Agaram NP, Qin LX, Kuk D, Curtin C, Brennan MF, Singer S (2016) Optimal percent myxoid component to predict outcome in high-grade myxofibrosarcoma and undifferentiated pleomorphic sarcoma. Ann Surg Oncol 23:818–825. https://​doi.​org/​10.​1245/​s10434-015-5063-5CrossRefPubMedPubMedCentral

go back to reference Song B, Lee K, Lee C, Moon KC (2018) Prognostic significance of microscopic tumor extension in local recurrence of myxofibrosarcoma and undifferentiated pleomorphic sarcoma. Pathol Int 68:509–516. https://doi.org/10.1111/pin.12709CrossRefPubMed Song B, Lee K, Lee C, Moon KC (2018) Prognostic significance of microscopic tumor extension in local recurrence of myxofibrosarcoma and undifferentiated pleomorphic sarcoma. Pathol Int 68:509–516. https://​doi.​org/​10.​1111/​pin.​12709CrossRefPubMed

go back to reference Yoo HJ, Hong SH, Kang Y, Choi JY, Moon KC, Kim HS, Han I, Yi M, Kang HS (2014) MR imaging of myxofibrosarcoma and undifferentiated sarcoma with emphasis on tail sign; diagnostic and prognostic value. Eur Radiol 24:1749–1757. https://doi.org/10.1007/s00330-014-3181-2CrossRefPubMed Yoo HJ, Hong SH, Kang Y, Choi JY, Moon KC, Kim HS, Han I, Yi M, Kang HS (2014) MR imaging of myxofibrosarcoma and undifferentiated sarcoma with emphasis on tail sign; diagnostic and prognostic value. Eur Radiol 24:1749–1757. https://​doi.​org/​10.​1007/​s00330-014-3181-2CrossRefPubMed

go back to reference Lefkowitz RA, Landa J, Hwang S, Zabor EC, Moskowitz CS, Agaram NP, Panicek DM (2013) Myxofibrosarcoma: prevalence and diagnostic value of the “tail sign” on magnetic resonance imaging. Skeletal Radiol 42:809–818. https://doi.org/10.1007/s00256-012-1563-6CrossRefPubMedPubMedCentral Lefkowitz RA, Landa J, Hwang S, Zabor EC, Moskowitz CS, Agaram NP, Panicek DM (2013) Myxofibrosarcoma: prevalence and diagnostic value of the “tail sign” on magnetic resonance imaging. Skeletal Radiol 42:809–818. https://​doi.​org/​10.​1007/​s00256-012-1563-6CrossRefPubMedPubMedCentral

go back to reference Imanishi J, Slavin J, Pianta M, Jackett L, Ngan SY, Tanaka T, Charoenlap C, Dib C, Choong PF (2016) Tail of superficial myxofibrosarcoma and undifferentiated pleomorphic sarcoma after preoperative radiotherapy. Anticancer Res 36:2339–2344PubMed Imanishi J, Slavin J, Pianta M, Jackett L, Ngan SY, Tanaka T, Charoenlap C, Dib C, Choong PF (2016) Tail of superficial myxofibrosarcoma and undifferentiated pleomorphic sarcoma after preoperative radiotherapy. Anticancer Res 36:2339–2344PubMed

go back to reference Kikuta K, Kubota D, Yoshida A, Morioka H, Toyama Y, Chuuman H, Kawai A (2015) An analysis of factors related to the tail-like pattern of myxofibrosarcoma seen on MRI. Skeletal Radiol 44:55–62. https://doi.org/10.1007/s00256-014-1992-5CrossRefPubMed Kikuta K, Kubota D, Yoshida A, Morioka H, Toyama Y, Chuuman H, Kawai A (2015) An analysis of factors related to the tail-like pattern of myxofibrosarcoma seen on MRI. Skeletal Radiol 44:55–62. https://​doi.​org/​10.​1007/​s00256-014-1992-5CrossRefPubMed

go back to reference Iwata S, Yonemoto T, Araki A, Ikebe D, Kamoda H, Hagiwara Y, Ishii T (2014) Impact of infiltrative growth on the outcome of patients with undifferentiated pleomorphic sarcoma and myxofibrosarcoma. J Surg Oncol 110:707–711. https://doi.org/10.1002/jso.23708CrossRefPubMed Iwata S, Yonemoto T, Araki A, Ikebe D, Kamoda H, Hagiwara Y, Ishii T (2014) Impact of infiltrative growth on the outcome of patients with undifferentiated pleomorphic sarcoma and myxofibrosarcoma. J Surg Oncol 110:707–711. https://​doi.​org/​10.​1002/​jso.​23708CrossRefPubMed

go back to reference Sambri A, Spinnato P, Bazzocchi A, Tuzzato GM, Donati D, Bianchi G (2019) Does pre-operative MRI predict the risk of local recurrence in primary myxofibrosarcoma of the extremities? Asia Pac J Clin Oncol. https://doi.org/10.1111/ajco.13161 Sambri A, Spinnato P, Bazzocchi A, Tuzzato GM, Donati D, Bianchi G (2019) Does pre-operative MRI predict the risk of local recurrence in primary myxofibrosarcoma of the extremities? Asia Pac J Clin Oncol. https://​doi.​org/​10.​1111/​ajco.​13161

go back to reference Morii T, Tajima T, Honya K, Aoyagi T, Ichimura S (2018) Clinical significance of the tail-like pattern in soft-tissue sarcomas on magnetic resonance imaging. J Orthop Sci 23:1032–1037. https://doi.org/10.1016/j.jos.2018.06.010CrossRefPubMed Morii T, Tajima T, Honya K, Aoyagi T, Ichimura S (2018) Clinical significance of the tail-like pattern in soft-tissue sarcomas on magnetic resonance imaging. J Orthop Sci 23:1032–1037. https://​doi.​org/​10.​1016/​j.​jos.​2018.​06.​010CrossRefPubMed

go back to reference Kaya M, Wada T, Nagoya S, Sasaki M, Matsumura T, Yamaguchi T, Hasegawa T, Yamashita T (2008) MRI and histological evaluation of the infiltrative growth pattern of myxofibrosarcoma. Skeletal Radiol 37:1085–1090. https://doi.org/10.1007/s00256-008-0542-4CrossRefPubMed Kaya M, Wada T, Nagoya S, Sasaki M, Matsumura T, Yamaguchi T, Hasegawa T, Yamashita T (2008) MRI and histological evaluation of the infiltrative growth pattern of myxofibrosarcoma. Skeletal Radiol 37:1085–1090. https://​doi.​org/​10.​1007/​s00256-008-0542-4CrossRefPubMed